FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003022010> ?p ?o ?g. }

• W3003022010 endingPage "104619" @default.
• W3003022010 startingPage "104619" @default.
• W3003022010 abstract "The optimal treatment strategy for residual stenosis in patients with acute intracranial atherosclerotic stenosis related occlusion (ICAS-O) after endovascular treatment (EVT) is unknown. This study aims to evaluate the efficacy and safety of low-dose tirofiban in patients with residual stenosis after EVT due to acute ICAS-O.Retrospective analysis of prospectively enrolled consecutive patients with residual stenosis after EVT due to acute ICAS-O from March 2015 to May 2019. Patients were divided into EVT alone group or EVT plus tirofiban group. The primary endpoint was the favorable functional outcome (defined as modified Rankin scale score of 0-2) at 90 days. The secondary endpoints were the proportions of reocclusion of recanalized arteries within 72 hours after EVT, symptomatic intracranial hemorrhage (sICH), any ICH, and mortality at 90 days. Logistic regression for predictors of reocclusion and functional outcomes were performed.A total of 98 patients, 50 treated with tirofiban and 48 without tirofiban, were enrolled in this study. Compared with patients in EVT alone group, patients in EVT plus tirofiban group had higher favorable functional outcome rate, lower mortality, and a lower reocclusion rate (56.3% versus 30.4%; P = .014, 8.3% versus 28.3%; P = .016, and 10.4% versus 32.6%; P = .011, respectively). The rates of any ICH and sICH were similar between the 2 groups. The use of tirofiban was associated with the favorable functional outcome (odds ratio [OR], 3.417; 95% confidence interval [CI], 1.149-10.163; P = .027) and lower reocclusion rate (OR, 0.145; 95% CI, 0.038-0.546; P = .004) on multivariate logistic regression analysis.In patients with residual stenosis after EVT due to acute ICAS-O, a low-dose of tirofiban is associated with favorable functional outcome and reduced incidence of reocclusion without increasing any ICH and sICH." @default.
• W3003022010 created "2020-01-30" @default.
• W3003022010 creator A5002982314 @default.
• W3003022010 creator A5006651636 @default.
• W3003022010 creator A5008155964 @default.
• W3003022010 creator A5011376657 @default.
• W3003022010 creator A5027150115 @default.
• W3003022010 creator A5041100767 @default.
• W3003022010 creator A5042223294 @default.
• W3003022010 creator A5043853124 @default.
• W3003022010 creator A5073260814 @default.
• W3003022010 creator A5074520078 @default.
• W3003022010 creator A5080901594 @default.
• W3003022010 date "2020-04-01" @default.
• W3003022010 modified "2023-09-29" @default.
• W3003022010 title "Efficacy and Safety of Low-Dose Tirofiban for Acute Intracranial Atherosclerotic Stenosis Related Occlusion with Residual Stenosis after Endovascular Treatment" @default.
• W3003022010 cites W1939078884 @default.
• W3003022010 cites W1964985037 @default.
• W3003022010 cites W2024652560 @default.
• W3003022010 cites W2044703373 @default.
• W3003022010 cites W2050880768 @default.
• W3003022010 cites W2056949443 @default.
• W3003022010 cites W2083415938 @default.
• W3003022010 cites W2104521758 @default.
• W3003022010 cites W2111066965 @default.
• W3003022010 cites W2117855158 @default.
• W3003022010 cites W2148656951 @default.
• W3003022010 cites W2156287977 @default.
• W3003022010 cites W2165636682 @default.
• W3003022010 cites W2277258071 @default.
• W3003022010 cites W2340401247 @default.
• W3003022010 cites W2514297902 @default.
• W3003022010 cites W2520316446 @default.
• W3003022010 cites W2584902370 @default.
• W3003022010 cites W2767687765 @default.
• W3003022010 cites W2891389754 @default.
• W3003022010 cites W2907523353 @default.
• W3003022010 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104619" @default.
• W3003022010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31982305" @default.
• W3003022010 hasPublicationYear "2020" @default.
• W3003022010 type Work @default.
• W3003022010 sameAs 3003022010 @default.
• W3003022010 citedByCount "22" @default.
• W3003022010 countsByYear W30030220102020 @default.
• W3003022010 countsByYear W30030220102021 @default.
• W3003022010 countsByYear W30030220102022 @default.
• W3003022010 countsByYear W30030220102023 @default.
• W3003022010 crossrefType "journal-article" @default.
• W3003022010 hasAuthorship W3003022010A5002982314 @default.
• W3003022010 hasAuthorship W3003022010A5006651636 @default.
• W3003022010 hasAuthorship W3003022010A5008155964 @default.
• W3003022010 hasAuthorship W3003022010A5011376657 @default.
• W3003022010 hasAuthorship W3003022010A5027150115 @default.
• W3003022010 hasAuthorship W3003022010A5041100767 @default.
• W3003022010 hasAuthorship W3003022010A5042223294 @default.
• W3003022010 hasAuthorship W3003022010A5043853124 @default.
• W3003022010 hasAuthorship W3003022010A5073260814 @default.
• W3003022010 hasAuthorship W3003022010A5074520078 @default.
• W3003022010 hasAuthorship W3003022010A5080901594 @default.
• W3003022010 hasConcept C126322002 @default.
• W3003022010 hasConcept C141071460 @default.
• W3003022010 hasConcept C151956035 @default.
• W3003022010 hasConcept C156957248 @default.
• W3003022010 hasConcept C164705383 @default.
• W3003022010 hasConcept C2776268601 @default.
• W3003022010 hasConcept C2776335557 @default.
• W3003022010 hasConcept C2780007028 @default.
• W3003022010 hasConcept C2780400711 @default.
• W3003022010 hasConcept C2780931571 @default.
• W3003022010 hasConcept C3020199598 @default.
• W3003022010 hasConcept C44249647 @default.
• W3003022010 hasConcept C500558357 @default.
• W3003022010 hasConcept C541997718 @default.
• W3003022010 hasConcept C71924100 @default.
• W3003022010 hasConceptScore W3003022010C126322002 @default.
• W3003022010 hasConceptScore W3003022010C141071460 @default.
• W3003022010 hasConceptScore W3003022010C151956035 @default.
• W3003022010 hasConceptScore W3003022010C156957248 @default.
• W3003022010 hasConceptScore W3003022010C164705383 @default.
• W3003022010 hasConceptScore W3003022010C2776268601 @default.
• W3003022010 hasConceptScore W3003022010C2776335557 @default.
• W3003022010 hasConceptScore W3003022010C2780007028 @default.
• W3003022010 hasConceptScore W3003022010C2780400711 @default.
• W3003022010 hasConceptScore W3003022010C2780931571 @default.
• W3003022010 hasConceptScore W3003022010C3020199598 @default.
• W3003022010 hasConceptScore W3003022010C44249647 @default.
• W3003022010 hasConceptScore W3003022010C500558357 @default.
• W3003022010 hasConceptScore W3003022010C541997718 @default.
• W3003022010 hasConceptScore W3003022010C71924100 @default.
• W3003022010 hasIssue "4" @default.
• W3003022010 hasLocation W30030220101 @default.
• W3003022010 hasLocation W30030220102 @default.
• W3003022010 hasOpenAccess W3003022010 @default.
• W3003022010 hasPrimaryLocation W30030220101 @default.
• W3003022010 hasRelatedWork W2037611947 @default.
• W3003022010 hasRelatedWork W2122595195 @default.
• W3003022010 hasRelatedWork W2141321823 @default.
• W3003022010 hasRelatedWork W2335988042 @default.

• next